Inhibition of GSK-3β as a target for cardioprotection: the importance of timing, location, duration and degree of inhibition

Author： Murphy Elizabeth   Steenbergen Charles  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.9, Iss.3, 2005-06, pp. : 447-456

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitochondria and GSK-3β in Cardioprotection Against Ischemia/Reperfusion Injury

By Miura Tetsuji   Tanno Masaya  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 3, 2010-06 ,pp. : 255-263

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of Mitochondrial Membrane Permeability as a Putative Pharmacological Target for Cardioprotection

By  

Current Medicinal Chemistry, Vol. 16, Iss. 33, 2009-11 ,pp. : 4382-4398

Bentham Science Publishers

Access to resources Recommend Favorite

Falcipain Inhibition as a Promising Antimalarial Target

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 5, 2012-03 ,pp. : 408-444

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of phosphatidylinositol 3-kinase

By Zahradka P.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 97-99

Informa Healthcare

Access to resources Recommend Favorite

Prostaglandin E2 synthase inhibition as a therapeutic target

By Iyer Jitesh P   Srivastava Punit K   Dev Rishabh   Dastidar Sunanda G   Ray Abhijit  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. : 849-865

Informa Healthcare

Access to resources Recommend Favorite